Bausch Health (BHC) Companies announced the commercial expansion of OraPharma into Canada and Puerto Rico. This strategic move reflects OraPharma’s commitment to improving oral health awareness, providing access to treatments within periodontal disease management, and strengthening partnerships with local distributors and dental professionals in these markets.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
- Bausch Health reports Q3 revenue $2.68B, consensus $2.63B
- Bausch Health sees FY25 revenue $10.05B-$10.25B, consensus $10.12B
- Bausch Health options imply 8.2% move in share price post-earnings
- Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge